MAPS PBC is leading a paradigm shift in mental healthcare. There are currently 13mm adults suffering from PTSD annually in the US alone. MAPS PBC is a leader in psychedelic drug development being the only company to have completed Phase 3 trials. MAPS is commercializing the use of MDMA for PTSD Therapy.

The AI-powered factory of the future

AI-powered platform is a tool designed to help security & operations teams – of Transit Hubs, Schools, Cities, stadiums, corporate offices & retail environments – with safety response / planning and overall facility efficiency. AIRIA integrates with existing network data sources, such as WiFi, requires no hardware, can be deployed in under 24-hours, and has limitless scalability.

The legal way for high-risk businesses to process payments, traditionally

Pride Vodka is a refreshing new drink with a mission. Pride donates 10% of the proceeds to LGBTQIA+ organizations. But unlike other companies, they put the power in the hands of the customer where they can scan the QR code on the Pride bottle to donate 10% to a local LGBTQIA+ charity of their choice.

NeuroX1 uses proprietary machine learning and computational biology to advance neurodegenerative treatments—shortening drug development timelines, improving patient outcomes, and reducing the cost burden on pharmaceutical companies.